- Home
- NXN vs DTIL Comparison
NXN vs DTIL Comparison
Compare NXN & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXN
- DTIL
- Stock Information
- Founded
- NXN 1992
- DTIL 2006
- Country
- NXN United States
- DTIL United States
- Employees
- NXN N/A
- DTIL N/A
- Industry
- NXN Trusts Except Educational Religious and Charitable
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- NXN Finance
- DTIL Health Care
- Exchange
- NXN Nasdaq
- DTIL Nasdaq
- Market Cap
- NXN 45.4M
- DTIL 51.6M
- IPO Year
- NXN N/A
- DTIL 2019
- Fundamental
- Price
- NXN $11.74
- DTIL $4.38
- Analyst Decision
- NXN
- DTIL Strong Buy
- Analyst Count
- NXN 0
- DTIL 2
- Target Price
- NXN N/A
- DTIL $47.00
- AVG Volume (30 Days)
- NXN 9.7K
- DTIL 210.5K
- Earning Date
- NXN 01-01-0001
- DTIL 08-07-2025
- Dividend Yield
- NXN 4.23%
- DTIL N/A
- EPS Growth
- NXN N/A
- DTIL N/A
- EPS
- NXN 0.24
- DTIL N/A
- Revenue
- NXN N/A
- DTIL $1,261,000.00
- Revenue This Year
- NXN N/A
- DTIL N/A
- Revenue Next Year
- NXN N/A
- DTIL $53.21
- P/E Ratio
- NXN $48.42
- DTIL N/A
- Revenue Growth
- NXN N/A
- DTIL N/A
- 52 Week Low
- NXN $10.64
- DTIL $3.61
- 52 Week High
- NXN $12.45
- DTIL $11.09
- Technical
- Relative Strength Index (RSI)
- NXN 69.02
- DTIL 40.05
- Support Level
- NXN $11.40
- DTIL $4.53
- Resistance Level
- NXN $11.92
- DTIL $5.13
- Average True Range (ATR)
- NXN 0.14
- DTIL 0.33
- MACD
- NXN 0.03
- DTIL -0.04
- Stochastic Oscillator
- NXN 68.42
- DTIL 8.42
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.